Evonik breaks ground at second methionine integration plant in Singapore

demand for DL-methine in animal nutrition continues to be strong, with more than 500 million euros invested in the new plant, andEvonik's methionine production capacity in Singapore will double to 300,000 metric tons per yearvmX
Essen/Singapore - Evonik Industries' plans to build another world-class DL-methine plant in Singapore are in full swingRecently, MrShandaman, Deputy Prime Minister and Minister of Economic and Social Policy Co-ordination of Singapore, attended the opening ceremony of the Win Innovation PlantThe new plant, with a total investment of more than 500 million euros and an annual production capacity of 150,000 metric tons, is expected to start production in 2019Evonik sells DL-methine products under the MetAMINO ® brandvmX
"Our methionine integrated plant on Jurong Island was put into operation at the end of 2014 and the business was a great success, which led us to build another plant"In Asia, demand for MetAMINO ® products in animal nutrition continues to grow rapidly, " said Inkaishi, chairman of Evonik Industries"In addition to methionine, the new plant will produce all strategically important precursor products to ensure product quality and supply stabilityvmX
　　"Singapore has proven to be the ideal place to provide our Asian customers with products and services," said Reiner Beste, Chairman of the Board of Directors of Evonik Nutrition and Consumer Chemicals LLC The new plant will create more than 150 local jobs "We are pleased to see that highly qualified people in this country will work for the win," Says Beste vmX
　　The new plant will increase Evonik's Annual Production Capacity in Asia ® by 300,000 metric tons, thereby increasing the annual production capacity of the world to 730,000 metric tons Currently, Evonik produces amino acid products at world-class plants in Antwerp, Belgium, Wetherspoon and Cologne, Alabama, USA, and Singapore vmX
　　DL-methionine is one of the essential amino acids in animal feed and must be absorbed by ingesting As a feed additive, it provides effective and balanced nutrition for livestock, especially poultry and pigs, while protecting resources and the environment and helping to ensure a sustainable supply of animal protein for a growing global population vmX
　　Evonik has more than 60 years of experience in producing essential amino acids, providing efficient and sustainable animal nutrition solutions to customers in more than 100 countries At present, Evonik is developing innovative feed additives other than amino acids to further enhance the efficacy of animal feed and create more value for customers Evonik's products and services in animal nutrition protect natural resources and reduce environmental impact, playing a vital role in the global production of healthy, economical foods vmX Image caption vmX Evonik's second methionine integrated plant in Singapore (left to right): vmX , Chairman of the Supervisory Board of Evonik Industrial Group, Dr Werner Mueller, chairman of the supervisory board of the evok industry group, vmX Evonik Southeast Asia, Australia, New Zealand Regional President Peter Meinshausen vmX , Dr Ma Xuanren , Chairman of the Singapore Economic Development Board , vmX , Mr Christian Kullmann , Vice Chairman of the Board of Directors of evok Industries Group , Mr vmX Mr Sundaman , Deputy Prime Minister and Minister of Economic and Social Policy Co-ordination of Singapore , vmX Dr Michael Witter, Ambassador of Germany to Singapore, Dr vmX , Dr Ralph Sven Kaufmann, Chief Operating Officer, vmX Dr Reiner Beste, Chairman of the Board of Directors of Evonik Nutrition and Consumer Chemicals LLC, dr vmX Dr Franck Furno Furno Information Improving business profitability and maintaining continued growth in corporate value are the core strategies of Evonik We combine business with global trends, namely health, nutrition, resource efficiency, globalization Evonik's development benefits from its innovative strength and integrated technology platform Evonik operates in more than 100 countries around the world In fy15, Evonik generated sales of approximately EUR 13.5 billion and operating profit (ebitda, interest, tax, depreciation and amortisation) of EUR 2.47 billion vmX
　　Evonik Has been producing specialty chemicals in Greater China since the late 1970s, including Chinese mainland, Hong Kong and Taiwan, and has extensive operations in the region since before Evonik Greater China is one of the driving forces for global economic growth and is constantly striving to achieve continued growth in greater China Evonik Greater China now employs approximately 3,000 people and generated sales of more than 1.3 billion euros in 2015 the demand for DL-methine in animal nutrition continues to be strong, with new plant investing more than 500 million euros, Evonik's methionine production capacity in Singapore will double to 300,000 metric tons per year vmX
　　Essen/Singapore - Evonik Industries' plans to build another world-class DL-methine plant in Singapore are in full swing Recently, Mr Shandaman, Deputy Prime Minister and Minister of Economic and Social Policy Co-ordination of Singapore, attended the opening ceremony of the Win Innovation Plant The new plant, with a total investment of more than 500 million euros and an annual production capacity of 150,000 metric tons, is expected to start production in 2019 Evonik sells DL-methine products under the MetAMINO ® brand vmX
　　"Our methionine integrated plant on Jurong Island was put into operation at the end of 2014 and the business was a great success, which led us to build another plant "In Asia, demand for MetAMINO ® products in animal nutrition continues to grow rapidly, " said Inkaishi, chairman of Evonik Industries "In addition to methionine, the new plant will produce all strategically important precursor products to ensure product quality and supply stability vmX
　　"Singapore has proven to be the ideal place to provide our Asian customers with products and services," said Reiner Beste, Chairman of the Board of Directors of Evonik Nutrition and Consumer Chemicals LLC The new plant will create more than 150 local jobs "We are pleased to see that highly qualified people in this country will work for the win," Says Beste vmX
　　The new plant will increase Evonik's Annual Production Capacity in Asia ® by 300,000 metric tons, thereby increasing the annual production capacity of the world to 730,000 metric tons Currently, Evonik produces amino acid products at world-class plants in Antwerp, Belgium, Wetherspoon and Cologne, Alabama, USA, and Singapore vmX
　　DL-methionine is one of the essential amino acids in animal feed and must be absorbed by ingesting As a feed additive, it provides effective and balanced nutrition for livestock, especially poultry and pigs, while protecting resources and the environment and helping to ensure a sustainable supply of animal protein for a growing global population vmX
　　Evonik has more than 60 years of experience in producing essential amino acids, providing efficient and sustainable animal nutrition solutions to customers in more than 100 countries At present, Evonik is developing innovative feed additives other than amino acids to further enhance the efficacy of animal feed and create more value for customers Evonik's products and services in animal nutrition protect natural resources and reduce environmental impact, playing a vital role in the global production of healthy, economical foods vmX Image caption vmX Evonik's second methionine integrated plant in Singapore (left to right): vmX , Chairman of the Supervisory Board of Evonik Industrial Group, Dr Werner Mueller, chairman of the supervisory board of the evok industry group, vmX Evonik Southeast Asia, Australia, New Zealand Regional President Peter Meinshausen vmX , Dr Ma Xuanren , Chairman of the Singapore Economic Development Board , vmX , Mr Christian Kullmann , Vice Chairman of the Board of Directors of evok Industries Group , Mr vmX Mr Sundaman , Deputy Prime Minister and Minister of Economic and Social Policy Co-ordination of Singapore , vmX Dr Michael Witter, Ambassador of Germany to Singapore, Dr vmX , Dr Ralph Sven Kaufmann, Chief Operating Officer, vmX Dr Reiner Beste, Chairman of the Board of Directors of Evonik Nutrition and Consumer Chemicals LLC, dr vmX Dr Franck Furno Furno Information Improving business profitability and maintaining continued growth in corporate value are the core strategies of Evonik We combine business with global trends, namely health, nutrition, resource efficiency, globalization Evonik's development benefits from its innovative strength and integrated technology platform Evonik operates in more than 100 countries around the world In fy15, Evonik generated sales of approximately EUR 13.5 billion and operating profit (ebitda, interest, tax, depreciation and amortisation) of EUR 2.47 billion vmX
　　Evonik Has been producing specialty chemicals in Greater China since the late 1970s, including Chinese mainland, Hong Kong and Taiwan, and has extensive operations in the region since before Evonik Greater China is one of the driving forces for global economic growth and is constantly striving to achieve continued growth in greater China Evonik Greater China now employs approximately 3,000 people and generated sales of more than 1.3 billion euros in 2015 vmX